Liraglutide ameliorates obesity-related nonalcoholic fatty liver disease by regulating Sestrin2-mediated Nrf2/HO-1 pathway
Xue Han, Chuanhua Ding, Guangdong Zhang, Ruiyan Pan, Yongping Liu, Na Huang, Ningning Hou, Fang Han, Wenjie Xu, Xiaodong Sun
Topics & Concepts
LiraglutideEndocrinologyInternal medicineAMPKNonalcoholic fatty liver diseaseGlucose homeostasisDiet-induced obeseFatty liverInsulin resistanceMedicineChemistryDiabetes mellitusBiochemistryType 2 diabetesEnzymeProtein kinase ADiseaseLiver Disease Diagnosis and TreatmentDiet, Metabolism, and DiseaseGenomics, phytochemicals, and oxidative stress